Avastinarmene var bedre med hensyn til progressionsfri overlevelse i ITT (intent- to- treat) populationen (tabel 6) i forhold til behandlingsarmene, der kun indeholdt kemoterapi
Superiority of the Avastin-containing arms versus the chemotherapy alone arms in the overall comparison was demonstrated in terms of progression-free survival in the ITT population (Table 6)